(Q38057161)

27 August 2017

title

The COPD control panel: towards personalised medicine in COPD. (English)

1 reference

27 August 2017

William MacNee

2

0 references

author name string

Alvar Agusti

series ordinal

1

1 reference

27 August 2017

language of work or name

English

0 references

publication date

1 November 2012

1 reference

27 August 2017

1 reference

27 August 2017

volume

68

1 reference

27 August 2017

issue

7

1 reference

27 August 2017

page(s)

687-690

1 reference

Characterisation of COPD heterogeneity in the ECLIPSE cohort

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2012-202772

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2012-202772

Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2012-202772

Addressing the complexity of chronic obstructive pulmonary disease: from phenotypes and biomarkers to scale-free networks, systems biology, and P4 medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2012-202772

Current controversies and future perspectives in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2012-202772

Network medicine: a network-based approach to human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2012-202772

Systems medicine and integrated care to combat chronic noncommunicable diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2012-202772

The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2012-202772

British Society for Rheumatology and British Health Professionals in Rheumatology guideline for the management of rheumatoid arthritis (after the first 2 years).

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2012-202772

Changes in forced expiratory volume in 1 second over time in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2012-202772

Efficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebo-controlled TORCH study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2012-202772

Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2012-202772

Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2012-202772

Development and Validation of an Improved, COPD-Specific Version of the St. George Respiratory Questionnaire.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2012-202772

Development and first validation of the COPD Assessment Test.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2012-202772

Identification and prospective validation of clinically relevant chronic obstructive pulmonary disease (COPD) subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2012-202772

Asthma patients' perception of their ability to influence disease control and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2012-202772

Physical activity in patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2012-202772

Clinical audit of COPD patients requiring hospital admissions in Spain: AUDIPOC study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2012-202772

Chronic obstructive pulmonary disease phenotypes: the future of COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2012-202772

Chronic Obstructive Pulmonary Disease Biomarker(s) for Disease Activity Needed—Urgently

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2012-202772

Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2012-202772

Inflammatory Biomarkers Improve Clinical Prediction of Mortality in Chronic Obstructive Pulmonary Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2012-202772

Preparing for Precision Medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2012-202772

Chronic Obstructive Pulmonary Disease: Beyond the Forced Expiratory Manoeuvre

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2012-202772

Avoiding confusion in COPD: from risk factors to phenotypes to measures of disease characterisation

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2012-202772

10.1136/THORAXJNL-2012-202772

21 January 2018

Identifiers

DOI

1 reference

27 August 2017

1 reference